2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter‐defibrillator programming and testing

2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter‐defibrillator programming and testing

Abstract The 2015 HRS/EHRA/APHRS/SOLAECE Expert Consensus Statement on Optimal Implantable Cardioverter‐Defibrillator Programming and Testing provided guidance on bradycardia programming, tachycardia detection, tachycardia therapy, and defibrillation testing for implantable cardioverter‐defibrillato...

Full description

Bibliographic Details
Main Authors:	Martin K. Stiles, Laurent Fauchier, Carlos A. Morillo, Bruce L. Wilkoff
Format:	Article
Language:	English
Published:	Wiley 2019-06-01
Series:	Journal of Arrhythmia
Subjects:	Antitachycardia pacing Bradycardia mode and rate Defibrillation testing Implantable cardioverter‐defibrillator Programming Sudden cardiac death
Online Access:	https://doi.org/10.1002/joa3.12178

Similar Items

2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing
by: Bruce L. Wilkoff, MD, FHRS, CCDS, et al.
Published: (2016-02-01)

Arrhythmic episodes in patients implanted with a cardioverter-defibrillator – results from the Prospective Study on Predictive Quality with Preferencing PainFree ATP therapies (4P)
by: François Regoli, et al.
Published: (2019-06-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

Analysis of arrhythmic episodes in patients with implanted cardioverter defibrillators and a high risk of sudden cardiac death
by: A. S. Postol, et al.
Published: (2019-11-01)

Termination of Ventricular Tachycardia with Antitachycardia Pacing after Ineffective Shock Therapy in an ICD Recipient with Hypertrophic Cardiomyopathy
by: Panagiotis N. Margos, et al.
Published: (2009-01-01)

Utilization of Subcutaneous Cardioverter-Defibrillator in Poland and Europe–Comparison of the Results of Multi-Center Registries
by: Maciej Kempa, et al.
Published: (2021-07-01)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
by: Mohammad-Ali Jazayeri, MD, et al.
Published: (2017-06-01)

Sudden Death Due to Thrombosis Associated with Implantable Cardioverter-Defibrillator Electrodes
by: Jose Maria Frutos Perez, et al.
Published: (2021-03-01)

Real world utilization and impact of the wearable cardioverter-defibrillator in a community setting
by: Aditi Naniwadekar, et al.
Published: (2017-05-01)

Subcutaneous implantable cardioverter defibrillator: Where do we stand?
by: Arindam Pande, et al.
Published: (2016-01-01)

The wearable cardioverter-defibrillator is needed for most high-risk patients
by: Byron K. Lee, MD, MAS
Published: (2020-08-01)

Usefulness of the wearable cardioverter defibrillator in patients in the early post-myocardial infarction phase with high risk of sudden cardiac death: A single-center European experience
by: Yusuke Kondo, M.D., Ph.D., et al.
Published: (2015-10-01)

The Subcutaneous Implantable Cardioverter-Defibrillator: A Practical Review and Real-World Use and Application
by: Mark E. Panna Jr, MD, FACC, FHRS, et al.
Published: (2016-02-01)

Reassessment of practical usage and accumulation of real‐world data of wearable cardioverter defibrillator (WCD) in Japan—Design paper for J‐WCDR study
by: Shinichi Niwano, et al.
Published: (2021-02-01)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
by: Krishnakumar Nair, et al.
Published: (2014-07-01)

Under-Utilization of Implantable Cardioverter Defibrillators in Patients with Heart Failure - The Current State of Sudden Cardiac Death Prophylaxis
by: Jayasree Pillarisetti, MD, et al.
Published: (2015-01-01)

An inappropriate pacing threshold increase after repeated electrical storm in a patient with implantable cardioverter defibrillator
by: Ye Zhu, et al.
Published: (2017-10-01)

Magnets and implantable cardioverter defibrillators: What′s the problem?
by: Yiliam F Rodriguez-Blanco, et al.
Published: (2013-01-01)

Azygos Vein Lead Implantation For High Defibrillation Thresholds In Implantable Cardioverter Defibrillator Placement
by: Naga VA Kommuri, et al.
Published: (2010-01-01)

An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting
by: Jun Kishihara, MD, et al.
Published: (2016-02-01)

Intermuscular pocket for subcutaneous implantable cardioverter defibrillator: Single-center experience
by: Paola Ferrari, MD, et al.
Published: (2016-06-01)

Analysis of electrotherapy of cardioverter defibrillators implanted for the primary prevention of sudden cardiac death
by: V. K. Lebedeva, et al.
Published: (2019-08-01)

Initial experience with the subcutaneous implantable cardioverter-defibrillator in a single Japanese center
by: Nobuhiro Nishii, MD, et al.
Published: (2017-08-01)

Managing cross talk between a subcutaneous implantable cardioverter-defibrillator and a dual-chamber unipolar pacemaker system
by: Konstantinos Kossidas, MD, FHRS, et al.
Published: (2017-12-01)

A novel cause of inappropriate subcutaneous implantable cardioverter-defibrillator therapies after a generator change
by: Timothy M. Markman, MD, et al.
Published: (2021-08-01)

Ventricular tachycardia detection with the subcutaneous implantable cardioverter-defibrillator: Tracing the cause of an absent tracing
by: Fadi Mansour, MD, et al.
Published: (2020-02-01)

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)Key Findings
by: Mehmet K. Aktas, MD, MBA, FHRS, et al.
Published: (2020-06-01)

Factors That Cause Concerns after Cardioverter Defibrillator Implantation
by: Olimpia Karczewska, et al.
Published: (2021-06-01)

Subcutaneous implantable cardioverter defibrillator in complex adult congenital heart disease. Results from the S-ICD “Monaldi Care” registry
by: Berardo Sarubbi, et al.
Published: (2021-05-01)

Epicardial cardioverter defibrillator implantation due to post-fontan ventricular tachycardia
by: Nikolaos A Papakonstantinou, et al.
Published: (2020-01-01)

PREVENTION OF SUDDEN CARDIAC DEATH BY IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: ANALYSIS OF LARGE-SCALE CLINICAL TRIALS AND RECOMMENDATIONS OF EUROPEAN SOCIETY OF CARDIOLOGY (2015)
by: N. V. Melnik
Published: (2018-01-01)

Cost-effectiveness of implantable cardioverter-defibrillator in today's world
by: Giuseppe Boriani, et al.
Published: (2014-01-01)

An unusual cause of implantable cardioverter defibrillator malfunction: Twiddler syndrome
by: Ufuk Eryılmaz, et al.
Published: (2013-10-01)

Psychological Problems of Patients with Implantable Cardioverter Defibrillators in Baghdad City.
by: Bayda'a A. Kareem
Published: (2014-04-01)

Combination of a leadless pacemaker and subcutaneous implantable cardioverter defibrillator therapy for a Japanese patient with prosthetic valve endocarditis
by: Ryo Ito, et al.
Published: (2019-04-01)

Complications and Mortality of Single Versus Dual Chamber Implantable Cardioverter Defibrillators
by: Ataallah Bagherzadeh, et al.
Published: (2006-04-01)

Patient characteristics and in‐hospital complications of subcutaneous implantable cardioverter‐defibrillator for Brugada syndrome in Japan
by: Iwanari Kawamura, et al.
Published: (2019-12-01)

OVERSENSING AS A CAUSE OF INAPPROPRIATE IMPLANTABLE CARDIOVERTER- DEFIBRILLATOR THERAPY - CASE REPORT
by: Tomislav Kostić, et al.
Published: (2013-12-01)

Implantable cardioverter-defibrillator oversensing due to electric shock
by: Jurčević Ružica, et al.
Published: (2010-01-01)

Living With Implantable Cardioverter Defibrillator: A phenomenological Study
by: Mohammad Abbasi, et al.
Published: (2014-11-01)